Non-statin cholesterol drugs may cut risk for liver cancer: study
At least one cholesterol absorption inhibitor has been linked to a 30% reduced risk of cancer..
Prior studies have found that statin medications can help lower liver cancer risks, and new research suggests that at least one non-statin cholesterol drug can do the same.
A US National Cancer Institute team has found the use of cholesterol absorption inhibitors is associated with a reduced risk for liver cancer.
